Changes in haemodynamics and body fluid volume due to enalapril in patients with essential hypertension on chronic diuretic therapy B. A. M. van SchaikG. G. GeyskesE. J. Dorhout Mees Originals Pages: 381 - 385
Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon T. GjørupO. J. HartlingS. L. Nielsen Originals Pages: 387 - 389
Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals W. KirchC. LogemannE. E. Ohnhaus Originals Pages: 391 - 395
Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosis P. H. HinderlingM. EckertP. Heizmann Originals Pages: 397 - 404
Hypotensive and antiplatelet actions of motapizone depend on dose and time after ingestion V. SchulzW. FischerV. Zietsch Originals Pages: 405 - 410
Inhibition of thrombocyte aggregation by oral motapizone and other drugs V. SchulzW. FischerV. Zietsch Originals Pages: 411 - 414
Beta-blocking effect and pharmacokinetics of pindolol in young and elderly hypertensive patients I. GretzerG. AlvánF. Sjöqvist Originals Pages: 415 - 418
Transdermal delivery of bupranolol: Pharmacodynamics and beta-adrenoceptor occupancy A. WellsteinH. KüppersD. Palm Originals Pages: 419 - 422
Pharmacokinetics of slow-release diltiazem and its effect on atrioventricular conduction in healthy volunteers A. GordinP. PohtoP. Männistö Originals Pages: 423 - 426
Safety and efficacy of alinidine in symptom-free asthmatics J. LicheyM. HoffmannT. Friedrich Originals Pages: 427 - 430
Comparison of a controlled-release tablet of salbutamol given twice daily with a standard tablet given four times daily in the management of chronic obstructive lung disease F. P. V. MaesenJ. J. Smeets Originals Pages: 431 - 436
Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarate H. SanerH. P. GurtnerA. Küpfer Originals Pages: 437 - 442
Treatment of hydatid disease with high oral doses of mebendazole P. J. LuderB. SiffertJ. Bircher Originals Pages: 443 - 448
Importance of oxidative polymorphism and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites A. E. Balant-GorgiaL. P. BalantG. Garrone Originals Pages: 449 - 455
Lithium therapy and the turnover of phosphatidylcholine in human erythrocytes O. PleulB. Müller-Oerlinghausen Originals Pages: 457 - 462
Pharmacokinetics of naproxen in elderly patients R. M. McVerryJ. LethbridgeM. L. E. Orme Originals Pages: 463 - 468
Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of a 100 mg slow-release formulation P. D. FowlerP. T. DawesP. A. Shotton Originals Pages: 469 - 472
Renal clearance of sulphinpyrazone in man E. G. W. M. LentjesF. G. M. RusselC. A. M. van Ginneken Originals Pages: 473 - 478
Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis H. AlbinJ. M. RagnaudC. Wone Originals Pages: 479 - 483
Activity of esterases in plasma from Ghanaian and British subjects F. M. WilliamsE. N. NicholsonM. D. Rawlins Originals Pages: 485 - 489
Therapeutic drug monitoring of digoxin: Help or hindrance? R. J. DobbsP. W. NicholsonC. J. A. O'Neill Short Communications Pages: 491 - 495
Urinary metabolites of caffeine in the premature infant R. GorodischerE. ZmoraM. J. Arnaud Short Communications Pages: 497 - 499
Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis G. L. TrainaM. G. GentileM. Bonati Short Communications Pages: 501 - 504
Response to tilting in hypertensive patients receiving ketanserin L. A. FerraraF. PasanisiS. Soro Letter To The Editors Pages: 505 - 506
